MARKER THERAPEUTICS (MRKR)
(Delayed Data from NSDQ)
$5.40 USD
+0.56 (11.57%)
Updated Jul 24, 2024 03:59 PM ET
After-Market: $5.53 +0.13 (2.41%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MRKR 5.40 +0.56(11.57%)
Will MRKR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MRKR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRKR
MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Tops Revenue Estimates
MRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MRKR
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024
Marker Therapeutics’ Promising Cancer Therapy Progress